limitlesscasinonodepositbonus2022| Biological shares: The subsidiary obtained the registration certificate for new veterinary drug of swine fever genetic engineering subunit vaccine
editor 2024-04-29 17:03:35 Finance 24
Securities Times e Company News, Biological Shares (600201)(600201) announced on the evening of April 29 that according to the national "Regulations on the Administration of Veterinary Drugs" and "Veterinary Drugs Registration Measures", after review by the Ministry of Agriculture and Rural Affairs, the company's wholly-owned subsidiary Jinyu Baoling Biopharmaceutical Co., Ltd. participated in research and developmentlimitlesscasinonodepositbonus2022The swine fever genetically engineered subunit vaccine (CHO-133D) is a new veterinary drug and has been issuedlimitlesscasinonodepositbonus2022The "New Veterinary Drug Registration Certificate" was issued.